Hydralazine Versus Labetalol for the Management of Hypertensive Disorders of Pregnancy

• Status: Completed
• Trial end date: 2013-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

Hypertensive crisis (defined as a systolic pressure > 160mmHg or a diastolic pressure > 110mmHg) in patients with a hypertensive disorder of pregnancy is a serious complication with severe and even deadly consequences. The management in this population had been studied, but no consensus has been reached with regards to which treatment is better. Our study will compare two drugs: Hydralazine and Labetalol for the management of hypertensive crisis.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Saint Thomas Hospital, Panama
• Treatments: Hydralazine; Labetalol

Criteria

Inclusion Criteria:

• Gestational age > 24 weeks.

• Hypertensive Crisis (systolic pressure > 160 mmHg / diastolic pressure < 110mmHg).

Exclusion Criteria:

• Known allergy to hydralazine.

• Known allergy to labetalol.

• Severe Bradycardia